• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Top 5 Risk Off Stocks Which Could Rescue Your Portfolio This Month

    11/28/23 8:27:05 AM ET
    $CVGW
    $PLAG
    $SPB
    $UPXI
    Specialty Foods
    Consumer Discretionary
    Packaged Foods
    Consumer Staples
    Get the next $CVGW alert in real time by email

    The most oversold stocks in the consumer staples sector presents an opportunity to buy into undervalued companies.

    The RSI is a momentum indicator, which compares a stock's strength on days when prices go up to its strength on days when prices go down. When compared to a stock's price action, it can give traders a better sense of how a stock may perform in the short term. An asset is typically considered oversold when the RSI is below 30, according to Benzinga Pro.

    Here’s the latest list of major oversold players in this sector, having an RSI near or below 30.

    Spectrum Brands Holdings, Inc. (NYSE:SPB)

    • Spectrum Brands Holdings reported a fourth-quarter 2023 sales decline of 1.2% year-on-year to $740.70 million. "We started increasing our investments in marketing and advertising during the fourth quarter and will continue that trend going forward," said David Maura, Chairman and Chief Executive Officer of Spectrum Brands. The company’s stock has a 52-week low of $48.97 .
    • RSI Value: 28.61
    • SPB Price Action: Shares of Spectrum Brands gained 0.5% to close at $66.58 on Monday.

    Planet Green Holdings Corp. (NYSE:PLAG)

    • The company’s stock fell 42% over the past month. It has a 52-week low of $0.33.
    • RSI Value: 28.86
    • PLAG Price Action: Shares of Planet Green fell 6.9% to close at $0.3407 on Monday.

    Upexi, Inc. (NASDAQ:UPXI)

    • Upexi posted a wider-than-expected quarterly loss. "Revenue for our fiscal first quarter 2024 grew 144% year-over-year and 53.5% sequentially driven by growth in both branded products and re-commerce," commented CEO of Upexi, Allan Marshall. "While our cost cutting measures are now beginning to yield material year-over-year decreases in operating expenses as a percentage of revenue, we have also continued to invest significantly in the future growth of our brands." The company’s stock has a 52-week low of $0.85.
    • RSI Value: 25.70
    • UPXI Price Action: Shares of Upexi fell 7.9% to close at $0.8750 on Monday.

    Calavo Growers, Inc. (NASDAQ:CVGW)

    • Calavo Growers posted upbeat quarterly earnings. “I am pleased with our performance in the third quarter. We achieved strong avocado margins as we concentrated our efforts on the fundamentals of our flagship avocado business,” said Lee E. Cole, President and Chief Executive Officer of Calavo Growers, Inc. The company’s 52-week low is $22.64.
    • RSI Value: 29.67
    • CVGW Price Action: Shares of Calavo Growers fell 5.1% to close at $23.08 on Monday.

    22nd Century Group, Inc. (NASDAQ:XXII)

    • 22nd Century entered into an agreement to sell substantially all of its GVB Biopharma Hemp/Cannabis operations. The company has a 52-week low of $0.2010.
    • RSI Value: 20.24
    • XXII Price Action: Shares of 22nd Century Group fell 6.3% to close at $0.2110 on Monday.

     

    Read More: Intuit, NetApp And 3 Stocks To Watch Heading Into Tuesday

    Get the next $CVGW alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $CVGW
    $PLAG
    $SPB
    $UPXI

    CompanyDatePrice TargetRatingAnalyst
    Upexi Inc.
    $UPXI
    8/4/2025$15.00Buy
    Alliance Global Partners
    Upexi Inc.
    $UPXI
    6/16/2025$16.00Neutral → Overweight
    Cantor Fitzgerald
    Spectrum Brands Holdings Inc.
    $SPB
    5/14/2025$106.00 → $86.00Buy
    Monness Crespi & Hardt
    Spectrum Brands Holdings Inc.
    $SPB
    2/7/2025$94.00 → $102.00Hold → Buy
    Canaccord Genuity
    Spectrum Brands Holdings Inc.
    $SPB
    5/10/2024$98.00 → $106.00Buy
    Monness Crespi & Hardt
    Spectrum Brands Holdings Inc.
    $SPB
    2/9/2024$87.00 → $98.00Buy
    Monness Crespi & Hardt
    Spectrum Brands Holdings Inc.
    $SPB
    2/9/2024$83.00 → $86.00Buy → Hold
    Canaccord Genuity
    Spectrum Brands Holdings Inc.
    $SPB
    11/20/2023$90.00 → $73.00Overweight → Equal Weight
    Wells Fargo
    More analyst ratings

    $CVGW
    $PLAG
    $SPB
    $UPXI
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Chief Executive Officer Marshall Allan bought $90,000 worth of shares (50,000 units at $1.80), increasing direct ownership by 1% to 4,046,261 units (SEC Form 4)

    4 - UPEXI, INC. (0001775194) (Issuer)

    12/23/25 7:53:48 PM ET
    $UPXI
    Medicinal Chemicals and Botanical Products
    Health Care

    Chief Executive Officer Marshall Allan was granted 1,600,000 shares and bought $310,500 worth of shares (150,000 units at $2.07), increasing direct ownership by 78% to 3,996,261 units (SEC Form 4)

    4 - UPEXI, INC. (0001775194) (Issuer)

    12/17/25 6:43:21 PM ET
    $UPXI
    Medicinal Chemicals and Botanical Products
    Health Care

    Director Salkind Gene bought $127,500 worth of shares (50,000 units at $2.55) (SEC Form 4)

    4 - UPEXI, INC. (0001775194) (Issuer)

    11/21/25 6:32:50 AM ET
    $UPXI
    Medicinal Chemicals and Botanical Products
    Health Care

    $CVGW
    $PLAG
    $SPB
    $UPXI
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Chief Executive Officer Lindeman Bruce John covered exercise/tax liability with 8,951 shares, decreasing direct ownership by 29% to 21,884 units (SEC Form 4)

    4 - CALAVO GROWERS INC (0001133470) (Issuer)

    1/5/26 9:14:03 PM ET
    $CVGW
    Specialty Foods
    Consumer Discretionary

    Chief Executive Officer Marshall Allan bought $90,000 worth of shares (50,000 units at $1.80), increasing direct ownership by 1% to 4,046,261 units (SEC Form 4)

    4 - UPEXI, INC. (0001775194) (Issuer)

    12/23/25 7:53:48 PM ET
    $UPXI
    Medicinal Chemicals and Botanical Products
    Health Care

    Chief Executive Officer Marshall Allan was granted 1,600,000 shares and bought $310,500 worth of shares (150,000 units at $2.07), increasing direct ownership by 78% to 3,996,261 units (SEC Form 4)

    4 - UPEXI, INC. (0001775194) (Issuer)

    12/17/25 6:43:21 PM ET
    $UPXI
    Medicinal Chemicals and Botanical Products
    Health Care

    $CVGW
    $PLAG
    $SPB
    $UPXI
    SEC Filings

    View All

    Amendment: SEC Form SCHEDULE 13G/A filed by Upexi Inc.

    SCHEDULE 13G/A - UPEXI, INC. (0001775194) (Subject)

    2/17/26 9:20:39 AM ET
    $UPXI
    Medicinal Chemicals and Botanical Products
    Health Care

    Amendment: SEC Form SCHEDULE 13G/A filed by Upexi Inc.

    SCHEDULE 13G/A - UPEXI, INC. (0001775194) (Subject)

    2/13/26 9:39:20 AM ET
    $UPXI
    Medicinal Chemicals and Botanical Products
    Health Care

    Upexi Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Other Events, Financial Statements and Exhibits

    8-K - UPEXI, INC. (0001775194) (Filer)

    2/10/26 5:15:30 PM ET
    $UPXI
    Medicinal Chemicals and Botanical Products
    Health Care

    $CVGW
    $PLAG
    $SPB
    $UPXI
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Upexi Reports Fiscal Second Quarter 2026 Financial Results

    Digital Asset Revenue was $5.1 Million for the Quarter Gross Profit Increased 126% YoY to $6.7 Million for the Quarter Conference Call Scheduled for Today, February 10, 2026, at 5:30 p.m. Eastern Time TAMPA, Fla., Feb. 10, 2026 (GLOBE NEWSWIRE) -- Upexi, Inc. (NASDAQ:UPXI) (the "Company" or "Upexi"),  a leading Solana-focused digital asset treasury company and consumer brands owner, today announced its financial results for the fiscal second quarter ended December 31, 2025. "Our conviction in the long-term opportunity for Solana and our strategy remains stronger than ever despite the challenging market environment over the last several months - dynamics which we view as cyclical, not s

    2/10/26 4:35:00 PM ET
    $UPXI
    Medicinal Chemicals and Botanical Products
    Health Care

    Upexi to Participate in A.G.P.'s Digital Asset Innovation Summit on February 22-25

    TAMPA, Fla., Feb. 09, 2026 (GLOBE NEWSWIRE) -- Upexi, Inc. (NASDAQ:UPXI) ("Upexi" or the "Company"), a leading Solana-focused digital asset treasury company and consumer brands owner, today announced that management will participate in one-on-one investor meetings at A.G.P.'s Digital Asset Innovation Summit on February 22-25, 2026, at the Park Hyatt in Beaver Creek, Colorado. A.G.P.'s Digital Asset Innovation SummitDate: February 22-25, 2026Location: Park Hyatt, Beaver Creek, ColoradoAttendees: Brian Rudick, Chief Strategy OfficerFormat: Investor Meetings To schedule a one-on-one meeting with Upexi's management team, please contact KCSA Strategic Communications at [email protected]. About

    2/9/26 8:00:00 AM ET
    $UPXI
    Medicinal Chemicals and Botanical Products
    Health Care

    Upexi Announces Pricing of $7.4 Million Registered Direct Offering With a Single Institutional Investor

    TAMPA, Fla., Feb. 06, 2026 (GLOBE NEWSWIRE) -- Upexi, Inc. (NASDAQ:UPXI) (the "Company" or "Upexi"), a leading Solana-focused digital asset treasury company and consumer brands owner, today announced that it has entered into a definitive agreement with a single institutional investor for the sale and issuance of 6,337,000 shares of common stock of the Company and warrants to purchase up to 6,337,000 shares of common stock at a combined offering price of $1.17 per share of common stock and accompanying warrant, in a registered direct offering. The warrants have an exercise price of $1.50 per share, will be exercisable immediately upon issuance, and will expire five (5) years following the d

    2/6/26 8:33:38 AM ET
    $UPXI
    Medicinal Chemicals and Botanical Products
    Health Care

    $CVGW
    $PLAG
    $SPB
    $UPXI
    FDA approvals

    Live FDA approvals issued by the Food and Drug Administration and FDA breaking news

    View All

    December 23, 2021 - FDA Authorizes Marketing of Tobacco Products that Help Reduce Exposure to and Consumption of Nicotine for Smokers Who Use Them

    For Immediate Release: December 23, 2021 Today, the U.S. Food and Drug Administration authorized the marketing of 22nd Century Group Inc.’s “VLN King” and “VLN Menthol King” combusted, filtered cigarettes as modified risk tobacco products (MRTPs), which help reduce exposure to, and consumption of, nicotine for smokers who use them. These are the first combusted cigarettes to be authorized as MRTPs and the second

    12/23/21 9:06:12 AM ET
    $XXII
    Medicinal Chemicals and Botanical Products
    Health Care

    $CVGW
    $PLAG
    $SPB
    $UPXI
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Alliance Global Partners initiated coverage on Upexi, Inc. with a new price target

    Alliance Global Partners initiated coverage of Upexi, Inc. with a rating of Buy and set a new price target of $15.00

    8/4/25 8:09:26 AM ET
    $UPXI
    Medicinal Chemicals and Botanical Products
    Health Care

    Upexi, Inc. upgraded by Cantor Fitzgerald with a new price target

    Cantor Fitzgerald upgraded Upexi, Inc. from Neutral to Overweight and set a new price target of $16.00

    6/16/25 7:42:40 AM ET
    $UPXI
    Medicinal Chemicals and Botanical Products
    Health Care

    Monness Crespi & Hardt reiterated coverage on Spectrum Brands with a new price target

    Monness Crespi & Hardt reiterated coverage of Spectrum Brands with a rating of Buy and set a new price target of $86.00 from $106.00 previously

    5/14/25 7:59:11 AM ET
    $SPB
    Industrial Machinery/Components
    Miscellaneous

    $CVGW
    $PLAG
    $SPB
    $UPXI
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by 22nd Century Group Inc.

    SC 13G/A - 22nd Century Group, Inc. (0001347858) (Subject)

    12/3/24 11:18:54 AM ET
    $XXII
    Medicinal Chemicals and Botanical Products
    Health Care

    Amendment: SEC Form SC 13G/A filed by 22nd Century Group Inc.

    SC 13G/A - 22nd Century Group, Inc. (0001347858) (Subject)

    11/14/24 5:56:57 PM ET
    $XXII
    Medicinal Chemicals and Botanical Products
    Health Care

    Amendment: SEC Form SC 13G/A filed by Calavo Growers Inc.

    SC 13G/A - CALAVO GROWERS INC (0001133470) (Subject)

    11/12/24 1:31:58 PM ET
    $CVGW
    Specialty Foods
    Consumer Discretionary

    $CVGW
    $PLAG
    $SPB
    $UPXI
    Leadership Updates

    Live Leadership Updates

    View All

    Calavo Growers Announces Leadership Transition

    Lee E. Cole to retire following four decades of distinguished leadership B. John Lindeman appointed President and Chief Executive Officer SANTA PAULA, Calif., Nov. 12, 2025 (GLOBE NEWSWIRE) -- Calavo Growers, Inc. (Nasdaq-GS: CVGW) (the "Company" or "Calavo"), a global leader in sourcing, packing and distribution of fresh avocados, tomatoes, papayas and processing of guacamole and other avocado products, today announced that Lee E. Cole will retire as President and Chief Executive Officer, effective December 8, 2025. B. John Lindeman, a member of Calavo's Board of Directors and former Calavo Chief Financial Officer, will succeed Mr. Cole as President and Chief Executive Officer. Mr. Lind

    11/12/25 7:35:00 AM ET
    $CVGW
    $HYFM
    Specialty Foods
    Consumer Discretionary
    Consumer Specialties

    Upexi Welcomes Jon Najarian to the Upexi Advisory Committee

    TAMPA, Fla., Oct. 23, 2025 (GLOBE NEWSWIRE) -- Upexi, Inc. (NASDAQ:UPXI), a brand owner specializing in the development, manufacturing, and distribution of consumer products with diversification into the cryptocurrency space, today announced the addition of Jon Najarian (Twitter: @jonnajarian) to the Upexi Advisory Committee, joining Arthur Hayes and S◎L Big Brain as founding Upexi Advisory Committee members. Jon Najarian is a highly influential figure in the world of finance, renowned for his deep expertise in options trading and market strategy. A former professional football player, Jon co-founded options trading firm Mercury Trading and later launched financial education company Marke

    10/23/25 8:00:00 AM ET
    $UPXI
    Medicinal Chemicals and Botanical Products
    Health Care

    Upexi Establishes Advisory Committee and Welcomes Arthur Hayes as First Member

    Additional members to join the Advisory Committee in the coming weeks to optimize performance, increase visibility and unlock capital raising opportunities Arthur brings deep expertise, exposure and connectivity to both digital assets and traditional finance TAMPA, Fla., Aug. 12, 2025 (GLOBE NEWSWIRE) -- Upexi, Inc. (NASDAQ:UPXI) (the "Company" or "Upexi"), a brand owner specializing in the development, manufacturing and distribution of consumer products with diversification into the cryptocurrency space, today announced the establishment of the Upexi Advisory Committee, composed of highly prominent individuals from the digital assets and traditional finance industries. Upexi will seek t

    8/12/25 8:00:00 AM ET
    $UPXI
    Medicinal Chemicals and Botanical Products
    Health Care

    $CVGW
    $PLAG
    $SPB
    $UPXI
    Financials

    Live finance-specific insights

    View All

    Spectrum Brands Holdings Reports Fiscal 2026 First Quarter Results

    First Quarter Net Sales Decreased 3.3% and Organic Net Sales Decreased 6.0% First Quarter Net Income From Continuing Operations of $29.4 Million and Adjusted EBITDA of $62.6 Million First Quarter Operating Cash Flow From Continuing Operations of $67.7 Million and Adjusted Free Cash Flow of $59.7 Million Repurchased 0.6 Million Shares in Q1 for $36 Million; New $300 Million Share Repurchase Authorization Approved Ended First Quarter with Net Debt Leverage of 1.65x Adjusted EBITDA Reiterating Fiscal 2026 Framework, Continue to Expect Net Sales to be Flat to Up Low Single Digits, Low Single Digit Growth in Adjusted EBITDA, and Approximately 50% Conversion of Adjusted EBITDA to

    2/5/26 6:30:00 AM ET
    $SPB
    Industrial Machinery/Components
    Miscellaneous

    Spectrum Brands Holdings Declares Quarterly Common Stock Dividend of $0.47 Per Share

    Spectrum Brands Holdings, Inc. (NYSE:SPB) announced that its Board of Directors today declared a quarterly dividend of $0.47 per share on the Common Stock of the Company. The dividend is payable on March 10, 2026 to shareholders of record as of February 17, 2026. About Spectrum Brands Holdings, Inc. Spectrum Brands is a home-essentials company with a mission to make living better at home. We focus on delivering innovative products and solutions to consumers for use in and around the home through our trusted brands. We are a leading supplier of specialty pet supplies, lawn and garden and home pest control products, personal insect repellents, shaving and grooming products, personal care

    2/3/26 5:30:00 PM ET
    $SPB
    Industrial Machinery/Components
    Miscellaneous

    Upexi to Host Second Quarter 2026 Earnings Call on February 10th at 5:30 p.m. ET

    TAMPA, Fla., Jan. 29, 2026 (GLOBE NEWSWIRE) -- Upexi, Inc. (NASDAQ:UPXI) (the "Company" or "Upexi"), a leading Solana-focused digital asset treasury company and consumer brands owner, today announced that it plans to host a conference call and report its financial results for the second quarter 2026 ended December 31, 2025, on Tuesday, February 10, 2026. Additional details are available under the Investor Relations section of the Company's website: https://ir.upexi.com/ Event:Upexi Second Quarter 2026 Earnings CallDate:Tuesday, February 10, 2026Time:5:30 p.m. ETLive Call:1-877-407-9716 (U.S. Toll-Free) or 1-201-493-6779 (International)Webcasthttps://ir.upexi.com/news-events/ir-calendar For

    1/29/26 8:00:00 AM ET
    $UPXI
    Medicinal Chemicals and Botanical Products
    Health Care